Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Abstract Background The use of third-line targeted therapy (TTT) in metastatic renal cell carcinoma (mRCC) is not well characterized and varies due to the lack of robust data to guide treatment decisions. This study examined the use of third-line therapy in a large international population. Objectiv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European urology 2017-02, Vol.71 (2), p.204-209
Hauptverfasser:	Wells, J. Connor, Stukalin, Igor, Norton, Craig, Srinivas, Sandy, Lee, Jae Lyun, Donskov, Frede, Bjarnason, Georg A, Yamamoto, Haru, Beuselinck, Benoit, Rini, Brian I, Knox, Jennifer J, Agarwal, Neeraj, Ernst, D. Scott, Pal, Sumanta K, Wood, Lori A, Bamias, Aristotelis, Alva, Ajjai S, Kanesvaran, Ravindran, Choueiri, Toni K, Heng, Daniel Y.C
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - mortality Carcinoma, Renal Cell - secondary Databases, Factual Female Humans Internationality Kidney Neoplasms - drug therapy Kidney Neoplasms - mortality Kidney Neoplasms - secondary Male Metastatic renal cell carcinoma Retrospective Studies Risk Assessment Survival Analysis Targeted therapy Third line therapy Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!